Editorials

Ambulatory Blood Pressure Monitoring: Technology with a Purpose

Am Fam Physician. 2003 Jun 1;67(11):2262-2271.

  Related Article

Hypertension and its sequelae are responsible for many visits to family physicians. Office-based measurement of blood pressure using aneroid or mercury sphygmomanometry is central to such visits. In this issue of American Family Physician, Marchiando and Elston1 review a different, but certainly not new, approach to measurement of blood pressure. Once regarded solely as a research instrument, noninvasive 24-hour ambulatory blood pressure monitoring (ABPM) has emerged as a useful tool for clinicians faced with the challenges of establishing accurate diagnoses and adjusting antihypertensive therapy. Among its many indications, ABPM can provide useful information in the evaluation of borderline hypertension, antihypertensive efficacy, suspected white coat hypertension, and treatment resistance.2

In addition to multiple automated readings taken during normal daily activities, ambulatory monitoring enables blood pressure to be measured during sleep and permits evaluation of circadian patterns in blood pressure. Some evidence indicates that these readings correlate more closely with surrogate measures of end organ damage than do office blood pressure (OBP) values.3 Furthermore, recent outcome studies have strengthened the belief that ABPM is superior to office blood pressure readings for cardiovascular risk stratification and can be successfully used to direct therapy.4,5 However, a recent Agency for Healthcare Quality and Research (AHRQ) Evidence Report points out that the literature in this field is insufficient, and more research is necessary to determine the most efficacious, practical, and cost-effective approach to measuring blood pressure.6

Despite advantages over traditional office measurements, diffusion of ABPM into routine practice is complicated by unique barriers. Access to the technology is often limited to academic medical centers, and ambulatory blood pressure measurements are generally lower than office measurements, even in nor-motensive patients, making direct correlations between ABPM and OBP difficult. This lack of normative data has been addressed through analysis of population-based registries, and Marchiando and Elston1 use a table in their article to summarize current ABPM thresholds for treatment.

Most hypertension intervention studies have used OBP exclusively for decisions regarding antihypertensive therapy, and OBP values provide the basis of our current operational thresholds for defining hypertension. Clinical guidelines emphasize OBP should remain the standard of measurement on which most medication interventions should be based, although they acknowledge that ABPM may be beneficial in certain situations by providing important information not available from OBP.3,7 While the cost-effectiveness of ABPM has been questioned,6 some evidence exists that ABPM technology is cost-neutral or saves money.811 At present, third-party reimbursement for the test remains highly variable, although Medicare now reimburses for patients with suspected white coat hypertension.

If made readily available, use of ambulatory monitoring will likely increase. This has been our experience after establishing an ABPM referral service for primary care physicians at the University of Iowa. Nearly two years after establishing this service, we find our physicians make routine and appropriate use of the technology for selected patients and integrate the results of ABPM into their clinical decision-making.

Which patients should receive ABPM? A carte blanche recommendation that ABPM should be performed on all patients with hypertension is certainly not a judicious use of resources and should be discouraged. Faced with the possibility of overusing this convenient technology, it is important to identify patients for whom ABPM is appropriate. As Marchiando and Elston1 point out, ABPM should supplement but not substitute office measurements. A series of multiple office or home blood pressure measurements has been shown to be as reliable as ABPM12,13; unfortunately, many patients fail to consistently obtain and provide these readings. Twenty-four hour ABPM is a logical progression. Based on our clinical experience and a review of the literature, we offer an algorithm (see accompanying figure) for appropriate use of ABPM that incorporates home and office measurements.14

Ambulatory Blood Pressure Monitoring

FIGURE.

Suggested algorithm for appropriate use of ABPM.

*--Major cardiovascular risk factors in patients with hypertension (Joint National Congress VI) include smoking, dyslipidemia, diabetes, age >60, gender (men and postmenopausal women), and family history of early cardiovascular disease.

**--The proportion of blood pressures during the monitoring period that are increased relative to preset thresholds (140/90 mm Hg awake, 120/80 mm Hg asleep). (CCD = clinical cardiovascular disease; TOD = target organ damage; ABPM = ambulatory blood pressure monitoring; SBP = systolic blood pressure.)

View Large

Ambulatory Blood Pressure Monitoring


FIGURE.

Suggested algorithm for appropriate use of ABPM.

*--Major cardiovascular risk factors in patients with hypertension (Joint National Congress VI) include smoking, dyslipidemia, diabetes, age >60, gender (men and postmenopausal women), and family history of early cardiovascular disease.

**--The proportion of blood pressures during the monitoring period that are increased relative to preset thresholds (140/90 mm Hg awake, 120/80 mm Hg asleep). (CCD = clinical cardiovascular disease; TOD = target organ damage; ABPM = ambulatory blood pressure monitoring; SBP = systolic blood pressure.)

Ambulatory Blood Pressure Monitoring


FIGURE.

Suggested algorithm for appropriate use of ABPM.

*--Major cardiovascular risk factors in patients with hypertension (Joint National Congress VI) include smoking, dyslipidemia, diabetes, age >60, gender (men and postmenopausal women), and family history of early cardiovascular disease.

**--The proportion of blood pressures during the monitoring period that are increased relative to preset thresholds (140/90 mm Hg awake, 120/80 mm Hg asleep). (CCD = clinical cardiovascular disease; TOD = target organ damage; ABPM = ambulatory blood pressure monitoring; SBP = systolic blood pressure.)

Hypertension will continue to be a significant problem faced by family physicians. Sensible and rational use of ABPM technology provides us with a useful tool to improve outcomes for carefully selected patients.

Michael E. Ernst, Pharm.D., BCPS, is an assistant professor (clinical), College of Pharmacy and Department of Family Medicine, University of Iowa, Iowa City. He completed his doctor of pharmacy degree at the University of Iowa, followed by a specialty pharmacy residency in family medicine. He is a board certified pharmacotherapy specialist and co-director of the ambulatory blood pressure monitoring service in the Family Care Center at the University of Iowa Hospitals and Clinics, Iowa City.

George R. Bergus, M.D., is an associate professor, Department of Family Medicine, the University of Iowa Roy J. and Lucille Carver College of Medicine. He is a graduate of the Medical College of Pennsylvania, Philadephia, and completed the family medicine residency at the University of Rochester, New York. He is board certified in family practice and has a CAQ in Geriatric Medicine and is codirector of the ambulatory blood pressure monitoring service in the Family Care Center at the University of Iowa Hospitals and Clinics.

Address correspondence to Michael E. Ernst, Pharm.D., BCPS., Department of Family Medicine, 200 Hawkins Dr., 01287-PFP, University of Iowa, Iowa City, IA 52242 (michael-ernst@uiowa.edu). Reprints are not available from the authors.

REFERENCES

1. Marchiando RJ, Elston MP. Automated ambulatory blood pressure monitoring: clinical utility in the family practice setting. Am Fam Physician. 2003;67:2343–50,2353–4.

2. O’Brien E, Coats A, Owens P, et al. Use and interpretation of ambulatory blood pressure monitoring: recommendations of the British Hypertension Society. BMJ. 2000;320:1128–34.

3. Verdecchia P. Prognostic value of ambulatory blood pressure: current evidence and clinical implications. Hypertension. 2000;35:844–51.

4. Staessen JA, Byttebier G, Buntinx F, et al. Anti-hypertensive treatment based on conventional or ambulatory blood pressure measurement. A randomized controlled trial. Ambulatory blood pressure monitoring and treatment of hypertension investigators. JAMA. 1997;278:1065–72.

5. Staessen JA, Thijs L, Fagard R, et al. Predicting cardiovascular risk using conventional versus ambulatory blood pressure in older patients with systolic hypertension. JAMA. 1999;282:539–46.

6. Utility of blood pressure monitoring outside of the clinic setting. Evidence report/technology assessment: Number 63. AHRQ Publication No. 03-E003, March 2002. Agency for Healthcare Research and Quality, Rockville, MD.

7. Sixth report of the Joint National Committee on detection, evaluation, and treatment of high blood pressure (JNC VI). Arch Intern Med. 1997;157:2413–46.

8. Moser M. Hypertension can be treated effectively without increasing the cost of care. J Hum Hypertens. 1996;10suppl 2:533–8.

9. Pierdomenico SD, Mezzetti A, Lapenna D, et al. ‘White-coat’ hypertension in patients with newly diagnosed hypertension: evaluation of prevalence by ambulatory monitoring and impact on cost of health care. Eur Heart J. 1995;16:692–7.

10. Yarows SA, Khoury S, Sowers JR. Cost effectiveness of 24-hour ambulatory blood pressure monitoring in evaluation and treatment of essential hypertension. Am J Hypertens. 1994;7:464–8.

11. Krakoff LR. Ambulatory blood pressure monitoring can improve cost-effective management of hypertension. Am J Hypertens. 1993;66 pt 2:220S–224S.

12. Jula A, Puukka P, Karanko H. Multiple clinic and home blood pressure measurements versus ambulatory blood pressure monitoring. Hypertension. 1999;34:261–6.

13. Yarows SA, Julius S, Pickering TG. Home blood pressure monitoring. Arch Intern Med. 2000;160:1251–7.

14. Ernst ME, Bergus GR. Noninvasive 24-hour ambulatory blood pressure monitoring: overview of technology and clinical applications. Pharmacotherapy. 2002;22:597–612.


Copyright © 2003 by the American Academy of Family Physicians.
This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP. Contact afpserv@aafp.org for copyright questions and/or permission requests.

Want to use this article elsewhere? Get Permissions


Article Tools

  • Print page
  • Share this page
  • AFP CME Quiz

Information From Industry

More in Pubmed

Navigate this Article